Literature DB >> 8996606

Resistance of mammalian tumor cells to inhibitors of DNA topoisomerase II.

W T Beck1, M K Danks, J S Wolverton, M Chen, B Granzen, R Kim, D P Suttle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8996606     DOI： 10.1016/s1054-3589(08)61136-9

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 1054-3589


× No keyword cloud information.
  4 in total

1.  Unanswered questions about multidrug resistance.

Authors:  W T Beck
Journal:  Cytotechnology       Date:  1996       Impact factor: 2.058

2.  Treatment of advanced colorectal cancer with doxorubicin combined with two potential multidrug-resistance-reversing agents: high-dose oral tamoxifen and dexverapamil.

Authors:  G Weinländer; G Kornek; M Raderer; M Hejna; C Tetzner; W Scheithauer
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 3.  Novel actions of inhibitors of DNA topoisomerase II in drug-resistant tumor cells.

Authors:  W T Beck; R Kim; M Chen
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

4.  Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.

Authors:  S Withoff; E G de Vries; W N Keith; E F Nienhuis; W T van der Graaf; D R Uges; N H Mulder
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.